Micro Labs Limited — Ketorolac Exporter Profile
Indian Pharmaceutical Exporter · #6 for Ketorolac · $3.0M export value · DGFT Verified
Micro Labs Limited is the #6 Indian exporter of Ketorolac with $3.0M in export value and 60 verified shipments. Micro Labs Limited holds a 2.6% market share in Ketorolac exports across 10 countries. The company exports 76 pharmaceutical products worth $463.6M across 21 therapeutic categories.
Micro Labs Limited — Ketorolac Export Profile: Buyers & Destinations
Where Does Micro Labs Limited Export Ketorolac?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $1.3M | 28 | 66.1% |
| GERMANY | $231.1K | 12 | 11.3% |
| NIGERIA | $100.0K | 2 | 4.9% |
| NETHERLANDS | $92.0K | 4 | 4.5% |
| UNITED KINGDOM | $72.2K | 2 | 3.5% |
| MEXICO | $59.6K | 3 | 2.9% |
| AUSTRALIA | $58.3K | 2 | 2.9% |
| BELGIUM | $43.5K | 4 | 2.1% |
| UNITED ARAB EMIRATES | $33.4K | 1 | 1.6% |
| MOROCCO | $73 | 2 | 0.0% |
Micro Labs Limited exports Ketorolac to 10 countries. The largest destination is UNITED STATES accounting for 66.1% of Micro Labs Limited's Ketorolac shipments, followed by GERMANY (11.3%) and NIGERIA (4.9%). These destinations reflect Micro Labs Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Ketorolac from Micro Labs Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| EVERSANA LIFE SCIENCE SERVICES, LLC | UNITED STATES | $1.0M | 21 |
| EVERSANA LIFE SCIENCE SERVICES LLC | UNITED STATES | $231.8K | 5 |
| MSK PHARMALOGISTIC GMBH | GERMANY | $185.1K | 10 |
| MICRO LABS GMBH | BELGIUM | $181.4K | 10 |
| MICRO NOVA PHARMACEUTICALS IND | NIGERIA | $100.0K | 2 |
| EVERSANA LIFE SCIENCE SERVICES,LLC | UNITED STATES | $83.6K | 2 |
| BROWN AND BURK UK LIMITED | UNITED KINGDOM | $50.0K | 1 |
| MEDSURGE HEALTHCARE PTY LTD | AUSTRALIA | $50.0K | 1 |
| MICROSYNERGY PHARMACEUTICALS FZCO | UNITED ARAB EMIRATES | $33.4K | 1 |
| COIMPORTEX SERVICIOS ADUANALES S.C. | MEXICO | $30.6K | 1 |
Micro Labs Limited supplies Ketorolac to 14 buyers globally. The largest buyer is EVERSANA LIFE SCIENCE SERVICES, LLC (UNITED STATES), followed by EVERSANA LIFE SCIENCE SERVICES LLC (UNITED STATES) and MSK PHARMALOGISTIC GMBH (GERMANY). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Ketorolac Export Value and How Much Does Micro Labs Limited Contribute?
India exported $49.5M worth of Ketorolac through 2,961 shipments from 351 suppliers to 124 countries, serving 638 buyers globally. Micro Labs Limited contributes $3.0M to this total, accounting for 2.6% of India's Ketorolac exports. Micro Labs Limited ships Ketorolac to 10 countries through 14 buyers.
What Is the Average Shipment Value for Micro Labs Limited's Ketorolac Exports?
Micro Labs Limited's average Ketorolac shipment value is $50.0K per consignment, based on 60 shipments totaling $3.0M. The largest destination is UNITED STATES (66.1% of Micro Labs Limited's Ketorolac exports).
How Does Micro Labs Limited Compare to Other Indian Ketorolac Exporters?
Micro Labs Limited ranks #6 among 351 Indian Ketorolac exporters with a 2.6% market share. The top 3 exporters are CAPLIN STERILES LIMITED ($11.5M), GLAND PHARMA LIMITED ($10.6M), GLAND PHARMA LTD ($9.7M). Micro Labs Limited processed 60 shipments to 10 destination countries.
What Ketorolac Formulations Does Micro Labs Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| KETOROLAC TROMETHAMINE OPHTHALMIC SOLUTI | $415.3K | 9 |
| KETOROLAC TROMETHAMINE OPHTHALMIC SOLUTION 0.5% W/V (1X5ML) - TAX INVOICE NO: 714201031 DT: 06.04.2024 | $150.0K | 3 |
| KETOROLAC TROMETHAMINE OPHTHALMIC SOLUTION 0.5% W/V (1X5ML) - TAX INVOICE NO: 714201255 DT: 28.02.2025 | $100.0K | 2 |
| KETOROLAC TROMETAMOL 0 5 W V EYE DROPSSOLUTION 1X5ML | $65.7K | 2 |
| KETOROLAC TROMETAMOL 0.5% W/V EYE DROPSSOLUTION (1X5ML) - TAX INVOICE NO: 714201312 DT: 29.04.2025 | $63.3K | 2 |
| TOROLAC EYE DROPS (KETOROLAC TROMETHAMIN | $50.0K | 1 |
| TOROLAC EYE DROPS KETOROLAC TROMETHAMIN | $50.0K | 1 |
| KETOROLAC TROMETAMOL EYE DROPS SOLUTION | $50.0K | 1 |
| KETOROLAC TROMETHAMINE OPHTHALMIC SOLUTION 0.5% W/V ANDA NO: 203410 NDC NO: 42571-137-26. 10ML | $50.0K | 1 |
| KETOROLAC TROMETHAMINE OPHTHALMIC SOLUTION 0.5% W/V 10ML QTY-34584.000 | $50.0K | 1 |
Micro Labs Limited exports 41 distinct Ketorolac formulations including tablets, capsules, syrups, and combination drugs. The top formulation is KETOROLAC TROMETHAMINE OPHTHALMIC SOLUTI with 9 shipments worth $415.3K.
Regulatory Requirements: Exporting Ketorolac to Key Markets
What Micro Labs Limited must comply with to export Ketorolac to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Germany — BfArM/EMA
Approval Process
Marketing Authorisation via Decentralized or Mutual Recognition Procedure under EU Directive 2001/83/EC. CTD Module 1–5 dossier required.
Timeline: 12–18 months via Decentralized Procedure
GMP & Export Requirements
EU GMP (EudraLex Vol. 4); GMP certificate from EU competent authority; WHO Prequalification accepted as supporting evidence
Certificate of Pharmaceutical Product (CPP) from CDSCO; Written Confirmation for API export per EU requirements; EU FMD serialization mandatory
Note: Indian manufacturers must hold EU GMP certificate. EU Falsified Medicines Directive (FMD) serialization and tamper-evident packaging mandatory.
Nigeria — NAFDAC
Approval Process
Drug registration under NAFDAC guidelines. WHO-type CPP from India required.
Timeline: 6–18 months
GMP & Export Requirements
WHO GMP compliance; NAFDAC conducts overseas plant inspections
Certificate of Pharmaceutical Product (CPP) from CDSCO India; NAFDAC import permit
Note: India is the largest pharma supplier to Nigeria. NAFDAC has intensified Indian site inspections.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Micro Labs Limited Compare to Nearest Ketorolac Exporters?
Exporters ranked immediately above and below #6 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $4.8M | 95 | 3 | $50.0K |
| 4 | ALEMBIC PHARMACEUTICALS LIMITED | $3.5M | 70 | 1 | $50.0K |
| 6 | MICRO LABS LIMITED ★ | $3.0M | 60 | 10 | $50.0K |
| 7 | ASPIRO PHARMA LIMITED | $1.2M | 26 | 7 | $45.6K |
| 8 | WEXFORD LABORATORIES PRIVATE LIMITED | $1.1M | 50 | 6 | $22.9K |
Micro Labs Limited ranks #6 among 351 Indian Ketorolac exporters. Average shipment value of $50.0K compared to the market average of $141.1K. The closest competitors by value are SUN PHARMACEUTICAL INDUSTRIES LIMITED and ALEMBIC PHARMACEUTICALS LIMITED.
Which Indian Ports Ship Ketorolac Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 337 | 11.4% |
| SAHAR AIR | 229 | 7.7% |
| NHAVA SHEVA SEA (INNSA1) | 227 | 7.7% |
| HYDERABAD ICD (INSNF6) | 127 | 4.3% |
| HYDERABAD AIR | 93 | 3.1% |
| DELHI AIR | 92 | 3.1% |
| DELHI AIR CARGO ACC (INDEL4) | 75 | 2.5% |
| HYDERABAD ICD | 74 | 2.5% |
Geopolitical & Trade Policy Impact on Micro Labs Limited's Ketorolac Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Micro Labs Limited. The Israel-Iran conflict has intensified tensions in the Red Sea, leading to increased shipping costs and potential delays. These disruptions can affect supply chain efficiency and profitability, necessitating strategic adjustments in logistics and distribution channels.
Conversely, the U.S.-China trade tensions have prompted the United States to diversify its pharmaceutical supply sources, creating an opportunity for Indian exporters to capture a larger market share. Micro Labs can leverage this shift by emphasizing its compliance with U.S. regulatory standards and ensuring a reliable supply chain.
The recent India-European Union Free Trade Agreement, signed in January 2026, is poised to eliminate tariffs on most European pharmaceutical exports to India. While this enhances market access for European manufacturers, it also intensifies competition for Indian exporters. Micro Labs must enhance its value proposition through innovation, cost efficiency, and adherence to EU regulatory standards to maintain its competitive edge. (en.wikipedia.org)
Micro Labs Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for pharmaceutical exporters. Micro Labs Limited has demonstrated a commitment to quality, as evidenced by its recognition as India’s Most Technically and Scientifically Advanced Pharmaceutical Manufacturing Company in 2024. This accolade reflects the company's adherence to stringent manufacturing practices and international guidelines. (einnews.com)
However, the evolving regulatory landscape, including the EU's Falsified Medicines Directive and the U.S. FDA's stringent quality requirements, necessitates continuous investment in compliance infrastructure. Micro Labs must proactively adapt to these changes to ensure uninterrupted market access and maintain its reputation for quality.
About Micro Labs Limited
Micro Labs Limited exports 76 products worth $463.6M. Beyond Ketorolac, top products include Amoxicillin, Potassium, Gabapentin, Losartan, Esomeprazole. View the complete Micro Labs Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ketorolac — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Ketorolac shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Micro Labs Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 60 individual customs records matching Micro Labs Limited exporting Ketorolac, covering 41 formulations to 10 countries via 14 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 124+ countries, 638+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Ketorolac Export Data from Micro Labs Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Micro Labs Limited's Ketorolac exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Micro Labs Limited
Full Company Profile →
76 products · $463.6M total trade · 21 categories
Ketorolac Stats
Company Overview
Top Products by Micro Labs Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Micro Labs Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ketorolac. For current shipment-level data, contact TransData Nexus.